Healthcare
Biotechnology
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
BUY
20 Jan 2023RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
11,609,704+19%
1,923,076
$13.00
$24,999,988.00
SELL
13 Jan 2023Gould Robert J
Interim President & CEO, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
499,864-1%
6,766
$15.00
$101,490.00
BUY
4 Jan 2023RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,628,259+1%
180,703
$7.28
$1,314,805.80
BUY
27 Dec 2022RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,505,925+0%
4,089
$5.99
$24,509.88
BUY
19 Dec 2022RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,501,836+1%
98,787
$5.90
$582,813.70
BUY
14 Dec 2022RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,403,049+34%
2,403,049
$5.44
$13,073,874.00
SELL
7 Jun 2022Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630-12%
71,435
$8.09
$577,894.90
SELL
2 Jun 2022Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630-11%
66,622
$8.00
$532,809.94
SELL
7 Apr 2022Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630-1%
5,631
$24.02
$135,228.47
SELL
1 Apr 2022Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630-15%
94,251
$24.16
$2,276,683.80
SELL
10 Aug 2021Moxham Christopher
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
0-100%
51,785
$17.60
$911,416.00
SELL
10 Aug 2021Stuart Bryan
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
0-100%
60,000
$20.42
$1,225,000.00
BUY
28 Jun 2021Oltmans Curtis Gale
SVP, General Counsel, Officer
Fulcrum Therapeutics, Inc.
(FULC)
1,088+100%
1,088
$9.01
$9,802.88
BUY
28 Jun 2021Morabito Christopher
Chief Medical Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
1,100+100%
1,100
$9.16
$10,076.00
BUY
28 Jun 2021Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
2,300+100%
2,300
$9.00
$20,700.00
BUY
28 Jun 2021GERAGHTY JAMES A
Director
Fulcrum Therapeutics, Inc.
(FULC)
90,714+12%
10,000
$9.16
$91,600.00
SELL
15 Mar 2021Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
506,630-1%
10,000
$12.16
$121,578.33
SELL
22 Feb 2021Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
15,212-24%
5,000
$14.72
$73,581.50
SELL
16 Feb 2021Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
518,303-1%
8,215
$14.27
$117,197.41
SELL
21 Jan 2021Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
15,212-30%
6,607
$14.00
$92,498.00
SELL
20 Jan 2021Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
524,845-1%
10,000
$12.08
$120,826.00
SELL
8 Jul 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
534,845-0%
2,500
$20.00
$50,000.00
SELL
8 Jul 2020Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088-2%
2,951
$20.00
$59,020.00
SELL
1 Jul 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
65,714-1%
1,071
$18.30
$19,599.30
SELL
30 Jun 2020Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088-0%
141
$20.00
$2,820.00
SELL
25 Jun 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
537,345-0%
2,500
$20.80
$51,992.00
SELL
25 Jun 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785-2%
1,459
$22.00
$32,098.00
SELL
10 Jun 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785-0%
401
$22.00
$8,822.00
SELL
9 Jun 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
539,845-0%
156
$20.00
$3,120.00
SELL
5 Jun 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
540,001-0%
3,433
$20.17
$69,251.16
SELL
4 Jun 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785-1%
677
$20.14
$13,632.03
SELL
3 Jun 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
543,434-0%
2,800
$20.09
$56,250.43
SELL
2 Jun 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785-0%
383
$20.16
$7,719.59
SELL
1 Jun 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
546,234-0%
2,802
$20.00
$56,040.00
SELL
28 May 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
549,036-0%
3,309
$20.04
$66,301.91
SELL
28 May 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785-1%
800
$20.01
$16,007.00
SELL
28 May 2020Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088-1%
2,232
$20.00
$44,640.00
SELL
27 May 2020Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088-0%
448
$20.00
$8,960.00
SELL
26 May 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
552,345-0%
2,500
$20.00
$50,000.00
SELL
26 May 2020Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088-0%
412
$20.00
$8,240.00
SELL
12 May 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785-2%
1,860
$18.00
$33,480.00
SELL
11 May 2020Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
21,071-26%
7,500
$16.00
$120,000.00
SELL
2 Mar 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
67,100-3%
2,143
$17.38
$37,254.78
SELL
24 Feb 2020Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
30,923-13%
5,000
$16.83
$84,152.88
SELL
19 Feb 2020Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
554,845-0%
2,500
$20.00
$50,000.00
SELL
19 Feb 2020Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088-4%
6,088
$20.00
$121,760.00
SELL
3 Feb 2020Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
68,928-3%
2,143
$17.33
$37,141.83
SELL
23 Jan 2020Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
33,833-12%
5,000
$17.22
$86,101.95
BUY
22 Jul 2019Casdin Capital, LLC
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
589,285+31%
140,000
$15.84
$2,217,495.00
BUY
22 Jul 2019Third Rock Ventures III, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
5,962,202+1%
81,250
$16.00
$1,300,000.00
BUY
22 Jul 20196 Dimensions Capital, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
559,821+26%
118,750
$16.00
$1,900,000.00
BUY
22 Jul 2019Third Rock Ventures IV, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
2,343,154+3%
81,250
$16.00
$1,300,000.00
BUY
22 Jul 2019Sanofi
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
558,035+20%
93,750
$16.00
$1,500,000.00
BUY
22 Jul 2019LEVIN MARK J
Director, 10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
5,962,202+1%
81,250
$16.00
$1,300,000.00